Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the
global population; its burden has grown in parallel with rising rates of type 2 diabetes …

It has been generally accepted that insulin resistance (IR) and reduced insulin secretory
capacity are the basic pathogenesis of type 2 diabetes mellitus (T2DM). In addition to …

Background: Non-alcoholic fatty liver disease is a chronic disease caused by the
accumulation of fat in the liver related to overweight and obesity, insulin resistance …

Background Although autonomic imbalance is associated with an increased risk for
metabolic disease, its effects on nonalcoholic fatty liver disease (NAFLD) remains unclear …

Weight cycling is a major challenge in obesity management. Caloric restriction is known to
promote this phenomenon, but the impact of macronutrient changes during dieting remains …

Stepped-care obesity treatments aim to improve efficiency by early identification of non-
responders and adjusting interventions but lack validated models. We trained a random …

Objective The aim of this study was to evaluate the relationship between the triglyceride and
glucose (TyG) index and nonalcoholic fatty liver disease (NAFLD) using a large, population …

Background Dulaglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA),
has been shown to reduce body weight and liver fat content in patients with type 2 diabetes …

Weight regain within one year after weight loss is frequently observed and is referred to as
yo-yo dieting or weight cycling. In this study, we explore the effects of yo-yo dieting on the …

Objective The objective of this study was to evaluate the effects of body weight variability
(BWV) on the occurrence of adverse liver outcomes in individuals with type 2 diabetes (T2D) …